{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:11:23Z","timestamp":1789071083076,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010874","name":"Shandong Provincial Department of Finance","doi-asserted-by":"publisher","award":["ZR2024QH438"],"award-info":[{"award-number":["ZR2024QH438"]}],"id":[{"id":"10.13039\/501100010874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clinbiochem.2025.111009","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:22:42Z","timestamp":1756945362000},"page":"111009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Elevated level of platelet factor 4 in follicular fluid is associated with polycystic ovary syndrome"],"prefix":"10.1016","volume":"140","author":[{"given":"Wenqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonglan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenchao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinbiochem.2025.111009_b0005","first-page":"105","article-title":"Hyperandrogenemia in women with polycystic ovary syndrome: prevalence, characteristics and association with body mass index","volume":"29","author":"Alexiou","year":"2017","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"key":"10.1016\/j.clinbiochem.2025.111009_b0010","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.111009_b0015","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","article-title":"Update on PCOS: consequences, challenges, and guiding treatment","volume":"106","author":"Hoeger","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.111009_b0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.clinbiochem.2025.111009_b0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","article-title":"Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy","volume":"182","author":"Patel","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.clinbiochem.2025.111009_b0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med."},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.111009_b0035","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"issue":"7","key":"10.1016\/j.clinbiochem.2025.111009_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073789","article-title":"Chronic low grade inflammation in pathogenesis of PCOS","volume":"22","author":"Rudnicka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.clinbiochem.2025.111009_b0045","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/beog.2000.0133","article-title":"Angiogenesis in ovarian follicular and luteal development","volume":"14","author":"Hazzard","year":"2000","journal-title":"Baillieres Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.111009_b0050","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0015-0282(00)00670-1","article-title":"Role of vascular endothelial growth factor in ovarian physiology and pathology","volume":"74","author":"Geva","year":"2000","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.111009_b0055","doi-asserted-by":"crossref","first-page":"R199","DOI":"10.1530\/REP-17-0597","article-title":"Ovarian angiogenesis in polycystic ovary syndrome","volume":"155","author":"Di Pietro","year":"2018","journal-title":"Reproduction"},{"issue":"1 Pt 1","key":"10.1016\/j.clinbiochem.2025.111009_b0060","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0002-9378(00)70519-9","article-title":"Angiogenesis of the ovary","volume":"182","author":"Abulafia","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2025.111009_b0065","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1530\/REP-09-0283","article-title":"Angiogenesis and vascular function in the ovary","volume":"138","author":"Robinson","year":"2009","journal-title":"Reproduction"},{"issue":"11","key":"10.1016\/j.clinbiochem.2025.111009_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113500","article-title":"Endogenous ovarian angiogenesis in polycystic ovary syndrome-like rats induced by low-frequency electro-acupuncture: the CLARITY three-dimensional approach","volume":"19","author":"Ma","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.111009_b0075","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/humrep\/deaa351","article-title":"Alteration in angiogenic potential of granulosa-lutein cells and follicular fluid contributes to luteal defects in polycystic ovary syndrome","volume":"36","author":"Patil","year":"2021","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.111009_b0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0035-1552582","article-title":"The emerging role of angiogenic factor dysregulation in the pathogenesis of polycystic ovarian syndrome","volume":"33","author":"Tal","year":"2015","journal-title":"Semin. Reprod. Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.111009_b0085","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V69.1.219.219","article-title":"Cloning and characterization of platelet factor 4 cDNA derived from a human erythroleukemic cell line","volume":"69","author":"Poncz","year":"1987","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.111009_b0090","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0038-1645072","article-title":"Human platelet factor 4 and its C-terminal peptides: heparin binding and clearance from the circulation","volume":"63","author":"Rucinski","year":"1990","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.111009_b0095","first-page":"941","article-title":"Interaction of PF4 (CXCL4) with the vasculature: a role in atherosclerosis and angiogenesis","volume":"104","author":"Aidoudi","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.clinbiochem.2025.111009_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.651009","article-title":"Platelet protein-related abnormalities in response to acute hypoglycemia in type 2 diabetes","volume":"12","author":"Moin","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.clinbiochem.2025.111009_b0105","doi-asserted-by":"crossref","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), Hum. Reprod. 19(1) (2004) 41\u201347.","DOI":"10.1093\/humrep\/deh098"},{"issue":"10","key":"10.1016\/j.clinbiochem.2025.111009_b0110","doi-asserted-by":"crossref","first-page":"E2016","DOI":"10.1210\/jc.2011-3441","article-title":"Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis","volume":"97","author":"Kaur","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.111009_b0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rbmo.2016.04.007","article-title":"The role of AMH in the pathophysiology of polycystic ovarian syndrome","volume":"33","author":"Garg","year":"2016","journal-title":"Reprod. Biomed. Online"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.111009_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.02.026","article-title":"Characterization of women with elevated antim\u00fcllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes","volume":"211","author":"Tal","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.111009_b0125","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.rbmo.2015.06.015","article-title":"Assessing ovarian response: antral follicle count versus anti-M\u00fcllerian hormone","volume":"31","author":"Fleming","year":"2015","journal-title":"Reprod. Biomed. Online"},{"issue":"7","key":"10.1016\/j.clinbiochem.2025.111009_b0130","first-page":"2248","article-title":"Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome","volume":"82","author":"Taylor","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.111009_b0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/blood.V53.1.47.47","article-title":"Antiheparin proteins secreted by human platelets. purification, characterization, and radioimmunoassay","volume":"53","author":"Rucinski","year":"1979","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.111009_b0140","first-page":"151","article-title":"Biochemistry of alpha granule proteins","volume":"22","author":"Holt","year":"1985","journal-title":"Semin. Hematol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.111009_b0145","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/eji.200939703","article-title":"CXCL4-induced monocyte survival, cytokine expression, and oxygen radical formation is regulated by sphingosine kinase 1","volume":"40","author":"Kasper","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.111009_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2010.10.011","article-title":"The role of the CXC chemokines platelet factor-4 (CXCL4\/PF-4) and its variant (CXCL4L1\/PF-4var) in inflammation, angiogenesis and cancer","volume":"22","author":"Vandercappellen","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7","key":"10.1016\/j.clinbiochem.2025.111009_b0155","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.celrep.2016.10.031","article-title":"PF4 promotes platelet production and lung cancer growth","volume":"17","author":"Pucci","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.clinbiochem.2025.111009_b0160","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cyto.2018.02.022","article-title":"CXCL4 and CXCL4L1 in cancer","volume":"109","author":"Ruytinx","year":"2018","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.111009_b0165","first-page":"115","article-title":"Increased plasma levels of platelet factor 4 and \u03b2-thromboglobulin in women with recurrent pregnancy loss","volume":"74","author":"Kotani","year":"2020","journal-title":"Acta Med. Okayama"},{"issue":"9","key":"10.1016\/j.clinbiochem.2025.111009_b0170","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1182\/blood.V91.9.3289","article-title":"Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization","volume":"91","author":"Perollet","year":"1998","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.clinbiochem.2025.111009_b0175","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1182\/blood.V100.9.3087","article-title":"Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway","volume":"100","author":"Sulpice","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.111009_b0180","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/JOE-15-0414","article-title":"Mechanisms of fibroblast growth factor signaling in the ovarian follicle","volume":"228","author":"Price","year":"2016","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.clinbiochem.2025.111009_b0185","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.anireprosci.2017.02.006","article-title":"Fibroblast growth factor 2 (FGF2) and vascular endothelial growth factor A (VEGFA) synergistically promote steroidogenesis and survival of cultured buffalo granulosa cells","volume":"179","author":"Mishra","year":"2017","journal-title":"Anim. Reprod. Sci."},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.111009_b0190","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/ahe.12180","article-title":"Angiogenesis in the ovary \u2013 the most important regulatory event for follicle and corpus luteum development and function in cow \u2013 an overview","volume":"45","author":"Berisha","year":"2016","journal-title":"Anat. Histol. Embryol."}],"updated-by":[{"DOI":"10.1016\/j.clinbiochem.2026.111160","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000}},{"DOI":"10.1016\/j.clinbiochem.2026.111160","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000}}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:01:33Z","timestamp":1789070493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912025001389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":38,"alternative-id":["S0009912025001389"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.111009","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated level of platelet factor 4 in follicular fluid is associated with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.111009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111009"}}